0001628280-26-034186 | 10-Q | XBRL Viewer

Print Document

INVESTMENTS - Debt Securities, Held-to-maturity, Nonaccrual (Details) $ in Thousands	Mar. 31, 2026 USD ($)
Investments, Debt and Equity Securities [Abstract]
Less than one year	$ 34,794
1-2 years	3,779
Total	$ 38,573

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

3 Months Ended

Mar. 31, 2026

Accounting Policies [Abstract]

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (GAAP) for interim financial information and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2025 and the related notes included in the Company’s Form 10-K filed on February 12, 2026 (2025 Form 10-K) with the U.S. Securities and Exchange Commission (SEC). The December 31, 2025 condensed consolidated balance sheet was derived from the audited consolidated financial statements as of that date. In management’s opinion, the unaudited interim consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the unaudited condensed consolidated financial statements.

The operating results for the three months ended March 31, 2026 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period.

Reclassifications

Certain prior period amounts were reclassified to conform to the current period presentation. These reclassifications did not have an impact on previously reported amounts.

Principles of Consolidation

The unaudited condensed consolidated financial statements include the accounts of Arteris, Inc. and its wholly-owned subsidiaries. All intercompany transactions and accounts have been eliminated.

Segment Information

The Company operates as a single operating segment. The chief operating decision maker (CODM) is the Company’s Chief Executive Officer, who makes resource allocation decisions and assesses performance based on financial information presented on a consolidated basis, accompanied by disaggregated revenue information. Accordingly, the Company has determined that it has a single reportable segment and operating segment.

Use of Estimates

The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Such estimates relate to, among others, revenue recognition, the useful lives of assets, assessment of recoverability of property, plant and equipment, fair value of investments, impairment of the equity method investment, fair values of goodwill and other intangible assets, including impairments, leases, allowance for credit losses, deferred tax assets and related valuation allowance, stock-based compensation, potential reserves relating to litigation and tax matters, collectability of certain receivables, fair value and amortization of deferred income, as well as other accruals or reserves. Actual results could differ from those estimates and such differences may be material to the unaudited condensed consolidated financial statements.

Cash, Cash Equivalents and Restricted Cash

The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. The Company’s cash equivalents include deposits in money market accounts which were unrestricted as to withdrawal or use and are stated at fair value. As of March 31, 2026, cash and cash equivalents consisted primarily of checking, savings, money market accounts, and highly liquid investments with original maturities of three months or less. Interest earned on cash and cash equivalents is included in other income (expense), net in the unaudited consolidated statements of operations.

As of both March 31, 2026 and December 31, 2025, the Company’s restricted cash balance was $0.3 million. The Company’s restricted cash balance as of March 31, 2026 was primarily related to a letter of credit for its facility lease agreement and collateralized cash for corporate credit cards. Restricted cash, current is included in prepaid expenses and other current assets and restricted cash, noncurrent is included in other assets on the consolidated balance sheets.

Concentrations of Credit Risk

Financial instruments that potentially subject us to concentration of credit risk consist of cash and cash equivalents, investments and accounts receivable. Cash is currently held in five financial institutions that the Company believes are creditworthy. Cash held at these financial institutions generally exceed federally insured limits. The Company is exposed to credit risk in the event of default by the financial institution holding its cash, cash equivalents, and investments to the extent recorded in the balance sheet. The Company has not experienced any losses to date related to these concentrations.

The Company’s accounts receivable are derived principally from revenue earned from customers located in Americas, Europe, Middle East and Asia Pacific regions.

Accounts receivable from the Company’s major customers representing 10% or more of total accounts receivable was as follows:


	As of
	March 31, 2026		December 31, 2025
Customer A	15	%	11	%
Customer B	*		13	%

* Customer accounted for less than 10% of total accounts receivable at period end.

Revenue from the Company’s major customers representing 10% or more of total revenue was as follows:


	Three Months Ended March 31,
	2026	2025
Customer A	*	12	%

* Customer accounted for less than 10% of total revenue in the period.

Business Combination of Cycuity

On January 14, 2026 the Company completed the acquisition of Cycuity (the Acquisition) for approximately $43.1 million, consisting of cash of $15.1 million, the Company’s common stock with a fair value of $19.0 million and earn-out consideration with a fair value of $9.0 million. The Company accounted for the acquisition of Cycuity by applying the acquisition method of accounting for business combinations, see Note 7, Business Combination.

Significant Accounting Policies

There have been no significant changes to the Company’s significant accounting policies during the three months ended March 31, 2026 from those disclosed in the annual consolidated financial statements for the year ended December 31, 2025, except for the following.

Business Combinations

The Company allocates the purchase price to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the purchase price over the fair value of these identifiable assets and liabilities is recorded as goodwill. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets. These estimates are based on information obtained from management of the acquired companies, the Company’s assessment of this information, and historical experience. Significant estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from acquired customers, acquired technology, and trade names from a market participant perspective, useful lives, and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. In addition, unanticipated events and circumstances may occur that may affect the accuracy or validity of such estimates, and if such events occur, the Company may be required to adjust the value allocated to acquired assets or assumed liabilities. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the Company’s consolidated statements of operations. Acquisition related costs, such as advisory, legal, accounting, valuation, other professional or consulting fees and integration costs, are expensed as incurred.

Stock-based Compensation

The Company measures equity classified stock-based awards, including stock options, restricted stock units (RSUs), and starting in the three months ended March 31, 2026, performance stock units (PSUs), granted to employees, directors, and non-employees based on the estimated fair values of the awards on the date of the grant. Stock-based compensation expense for awards with service-based vesting is recognized on a straight-line basis over the requisite service period, which is generally the vesting period of such awards, as a component of operating expenses within the consolidated statements of operations. The Company accounts for forfeitures related to these awards as they occur.

The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. This valuation model for stock-based compensation expense requires the Company to make assumptions and judgments about the variables used in the calculation including the expected term, the volatility of the Company’s common stock, and an assumed risk-free interest rate.

The fair value of RSUs granted is measured as the fair value per share of the Company’s common stock on the date of grant.

For PSUs that include a market condition, the Company determines the grant date fair value of the award using a Monte Carlo valuation model and recognizes compensation cost on a straight-line basis over the requisite service period. Stock-based compensation expense for PSUs that include market conditions is based on the grant-date fair value and is recognized regardless of whether the market condition is ultimately achieved.

The Company adopted the 2021 Employee Stock Purchase Plan (the 2021 ESPP) effective on October 26, 2021. The 2021 ESPP provides for six-month offering periods beginning May 22 and November 22 of each year, and each offering period consists of a six-month purchase period. The first offering under the 2021 ESPP began on May 22, 2024, and ended on November 21, 2024. Eligible employees are entitled to purchase common stock at the end of six-month offering periods, by means of limited payroll deductions, at a 15% discount from the fair market value of the common stock as of specific dates.

The fair value of shares of common stock to be issued under the 2021 ESPP is estimated using the Black-Scholes option pricing model, which is impacted by the fair value of the Company’s common stock, as well as changes in assumptions regarding a number of subjective variables. These variables include the expected common stock price volatility over the term of the awards, the expected term of the awards, and the risk-free interest rate. Stock-based compensation expense for ESPP awards is recognized on a straight-line basis over the term of each ESPP offering period.

Revenue Recognition

The Company recognizes revenue in accordance with ASC Topic 606, Revenue from Contracts with Customers, and subsequently issued additional related ASUs (Topic 606). The Company recognizes revenue as it transfers control of deliverables (software and services) to its customers in an amount reflecting the consideration to which it expects to be entitled. To recognize revenues, the Company applies the following five step approach: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied. The Company accounts for a contract when it has approval and commitment from all parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. The Company applies judgment in determining the customer’s ability and intention to pay based on a variety of factors including the customer’s historical payment experience.

Nature of Products and Services

The Company’s revenue is primarily derived from licensing intellectual property, licensing software, support and maintenance services, professional services, training services, and royalties.

Design Solutions

Interconnect Solutions product arrangements provide customers the right to software licenses, services, and support and maintenance. The Company enters into licensing arrangements with customers that typically range from two to three years and generally consist of delivery of a design license that grants the customer the right to use the IP to design a contractually defined number of products, a right to access the benefits of its proprietary software tool (RTL), and support and maintenance services that provide the customer a significant benefit from ongoing access to Corporate Application Engineers (CAE) and Field Application Engineers (FAE) (collectively, Application Engineering Support Services) to perform certain verifications including benchmark performance, simulations and ultimately, through the RTL, instantiate designs into silicon over the design term.

Application Engineering Support Services are integral and fundamental to the customer’s ability to derive its intended benefit from the IP. Besides Application Engineering Support Services, support and maintenance services also consist of a stand-ready obligation to provide technical support and software updates over the support term. Generally, the first year of technical support and software updates are bundled with and into the license fee, with a customer option to renew additional years of support throughout the license term. However, the Company typically continues to provide technical support and software updates throughout the license term even if the customer does not renew these services in subsequent years, making the license term and support and maintenance term co-terminus.

Considering the nature of the combined license and assisting the Company’s customers in applying its IP technology in its customers’ development environment and the relative significance thereof, the Company has concluded that its promise to provide an Interconnect Solutions IP license is not distinct from its obligation to provide the Application Engineering Support Services and benefits of the RTL. Customers cannot benefit from the design license on its own; the Interconnect Solutions IP, RTL, and the Application Engineering Support Services serve to fulfill its commitment to the customer, as they represent inputs to a single, combined performance obligation that commences upon the later of the arrangement effective date or transfer of the software license. Further, although technical support and software updates is a distinct performance obligation, it is accounted for as if it were part of a single performance obligation that includes the licenses, RTL and Application Engineering Support Services because the technical support and updates are provided in practice for the same period of time and have the same time-based pattern of transfer to the customer as the combined design license, RTL, and Application Engineering Support Services. Therefore, revenue from Interconnect Solutions IP licensing arrangements is recognized ratably over the design term.

Revenues that are derived from the sale of a licensee’s products that incorporate the Company’s IP are classified as royalty revenues. Royalty revenues are recognized during the quarter in which the sale of the product incorporating the Company’s IP occurs and are included in variable royalties in the consolidated statements of operations. Royalties are calculated either as a percentage of the revenues received by a licensee’s sale of products incorporating the Company’s IP or on a per unit basis, as specified in the agreements with the licensees. For the majority of the Company’s royalty revenues, it receives the actual sales data from its customers after the quarter ends and accounts for it as unbilled receivables. In such instances, the Company recognizes royalty revenues based on its estimation of the customer’s sales during the quarter.

SoC Integration Automation Software Solutions

The Company’s SoC Integration Automation software solutions, CSRCompiler and hardware security verification software product arrangements provide customers the right to software licenses, software updates and technical support. The software licenses are time-based licenses with terms generally ranging from one to three years. These arrangements generally have two distinct performance obligations that consist of transferring the licensed software and the support and maintenance service. Support and maintenance services consist of a stand-ready obligation to provide technical support and software updates over the support term. Majority of the Company’s SoC Integration Automation software solutions contracts include termination rights that allow the customer to cancel and receive a pro-rata refund on support and maintenance services at the end of each month of the contract period, which results in a ratable recognition of the related license revenue over the contract term. The Company records obligations for refunds in accrued expenses and other current liabilities on the consolidated balance sheets.

Hardware Security Verification Software

The Company’s hardware security verification software product arrangements which were derived from the acquisition of Cycuity that closed in January 2026, provide customers the right to software licenses, software updates and technical support. The software licenses are time-based licenses with terms generally ranging from one to three years and generally provide the customer with limited rights to receive certain quantities of licensed software. In addition to the licenses, the arrangements also include: support and maintenance services, provided by Application Engineering Support Services, which includes providing frequent updates and upgrades to maintain the utility of the software due to rapid changes in technology. Updates are generally made available throughout the entire term of the arrangement. The updates provide continued access to evolving technology as customers’ designs migrate to more advanced nodes and as customers’ technological requirements evolve. The Company concluded that its hardware security verification software product licenses are not distinct from its obligation to provide unspecified software updates to the licensed software throughout the license term. Such updates represent inputs to a single, combined performance obligation, commencing upon the later of the arrangement effective date or transfer of control to the software license, leading to ratable recognition of the related license revenue over the contract term.

Professional Services

The Company’s agreements may include service elements (other than maintenance and support services). These services include training, design assistance, and consulting, and may include implementation, integration, or security verification. Such services are typically provided by the Company or by third-party subcontractors under contracts and task orders with the U.S. government for which the Company acts as the prime contractor. Labor and services performed by third-party subcontractors related to contracts with the U.S. government are recognized as professional services revenue. The related costs are recorded as cost of revenue in the same period in which the associated revenue is recognized. Professional services agreements are invoiced on a fixed fee or time and materials basis. Revenue is recognized over the period the services are provided, generally on a cost-to-cost basis.

Multiple Performance Obligations

Most of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the Company accounts for individual performance obligations separately, if they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis, which are estimated considering multiple factors including observable industry pricing practices and internal pricing strategies and objectives. Standalone selling prices of professional services are typically estimated based on observable transactions when these services are sold on a standalone basis.

Transaction Price

Revenue is recognized when, or as, control of a promised product or service transfers to a client, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring those products or services. If the consideration promised in a contract includes a variable amount, the Company estimates the amount to which it expects to be entitled using either the expected value or most likely amount method, to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur. Generally, the transaction price of the Company’s contracts is fixed at the inception of the contract, except for variable royalties. The Company’s contracts generally do not include terms that could cause variability in the transaction price.

The Company assesses the timing of the transfer of goods or services to the customer as compared to the timing of payments to determine whether a significant financing component exists. As a practical expedient, the Company does not assess the existence of a significant financing component when the difference between payment and transfer of deliverables is a year or less. If the difference in timing arises for reasons other than the provision of finance to either the customer or the Company, no financing component is deemed to exist. When contracts involve a significant financing component, the Company adjusts the promised amount of consideration for the effects of the time value of money if the timing of payments agreed to by the parties to the contract (either explicitly or implicitly) provide the customer with a significant benefit of financing.

The Company reports revenue net of any revenue-based taxes assessed by governmental authorities that are imposed on and concurrent with specific revenue-producing transactions.

In instances where foreign licensees withhold and remit taxes to local authorities in accordance with local laws and regulations, the Company recognizes and presents revenue on a gross basis and includes the withholding tax in income tax expense.

Flexible Spending Accounts

Some customers enter into a non-cancelable flexible spending account agreement (FSA Agreement) whereby the customer commits to a fixed dollar amount over a specified period of time that can be used to purchase from a list of the Company’s products or services. These agreements do not meet the definition of a revenue contract until the customer executes a separate order to identify the required products and services that they are purchasing. Each separate order under the agreement is treated as an individual contract and accounted for based on the respective performance obligations included within the FSA agreements.

Contract Modifications

The Company’s contracts may be modified to add, remove or change existing performance obligations. The accounting for modifications to the Company’s contracts involves assessing whether the products and services added to an existing contract are distinct and whether the pricing is at the standalone selling price. Products and services added that are not distinct are accounted for on a cumulative catch-up basis, while those that are distinct are accounted for prospectively, either as a separate contract if the additional services are priced at the standalone selling price, or as a termination of the existing contract and creation of a new contract if not priced at the standalone selling price. The Company’s more significant contract modifications include extensions of the design license term and the purchase of additional years of support and maintenance.

Judgments

The Company’s contracts with customers often include promises to transfer multiple products and services to a customer. Determining whether products and services are considered distinct performance obligations that should be accounted for separately versus together requires significant judgment. Judgment is also required to determine the standalone selling price for each distinct performance obligation.

Contract Balances

The timing of revenue recognition may differ from the timing of invoicing to customers, and these timing differences result in contract assets (unbilled receivables), or contract liabilities (deferred revenue) on the Company’s consolidated balance sheets. The Company records a contract asset when revenue is recognized prior to invoicing, and it has an unconditional right to invoice and receive payment. The Company records deferred revenue when it invoices customers and revenue is not yet recognized. Customers are generally invoiced in single or annual amounts, although some customers are invoiced more frequently over time.

The Company capitalizes sales commission as costs of obtaining a contract when they are incremental and, if they are expected to be recovered, amortized in a manner consistent with the pattern of transfer of the good or service to which the asset relates.

Recent Accounting Pronouncements

Recently Adopted Accounting Pronouncements

In July 2025, the FASB issued ASU 2025-05, Financial Instruments - Credit Losses (Topic 326), which provides all entities with a practical expedient to assume that current conditions as of the balance sheet date do not change for the remaining life of current accounts receivable and contract assets. This ASU is effective for fiscal years beginning after December 15, 2025 and interim reporting periods within those annual reporting periods, with early adoption permitted. The adoption of ASU 2025-05 did not have a significant impact on the Company’s consolidated financial statements.

Recently Issued Accounting Pronouncements Not Yet Adopted

In December 2025, the FASB issued ASU 2025-12, Codification Improvements, to address suggestions received from stakeholders on the ASC and to make other incremental improvements to GAAP. The update represents changes to the codification that (1) clarify, (2) correct errors, or (3) make other improvements that are intended to make it easier to understand and apply. The guidance is effective for fiscal years beginning after December 15, 2026, including interim periods within those fiscal years. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.

In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements, to amend the guidance in Topic 270. The update provides clarifications intended to improve the consistency and usability of interim disclosure requirements, including a comprehensive listing of required interim disclosures and a new disclosure principle for reporting material events occurring after the most recent annual period. The amendments do not change the underlying objectives of interim reporting but are designed to enhance clarity in application. This ASU is effective for fiscal years beginning after December 15, 2027 and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.

In December 2025, the FASB issued ASU 2025-10, Accounting for Government Grants Received by Business Entities. This ASU establishes the accounting and presentation for government grants received by a business entity under Government Grants (Topic 832). This ASU is effective for fiscal years beginning after December 15, 2028 and interim reporting periods within those annual reporting periods, with early adoption permitted. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.

In September 2025, the FASB issued ASU 2025-06, Targeted Improvements to the Accounting for Internal-Use Software, which modernizes the accounting for internal-use software costs and clarifies criteria for capitalization. This ASU is effective for fiscal years beginning after December 15, 2027 and interim reporting periods within those annual reporting periods, with early adoption permitted as of the beginning of an annual period. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.

In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, and in January 2025, the FASB issued ASU 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures, which requires incremental disclosures to disaggregate certain income statement expense line items on an annual and interim basis. ASU 2024-03, as clarified by ASU 2025-01, is effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting these ASUs on its consolidated financial statements and disclosures.

DESCRIPTION OF BUSINESS	3 Months Ended
DESCRIPTION OF BUSINESS	Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]
DESCRIPTION OF BUSINESS	DESCRIPTION OF BUSINESS Arteris, Inc. was incorporated in Delaware on April 12, 2004. Arteris, Inc. and its subsidiaries (collectively, the Company or Arteris) develop, license, and support the on-chip interconnect fabric technology used in System-on-Chip (SoC) designs for a variety of devices and in the development and distribution of Network-on-Chip (NoC) interconnect intellectual property (IP). The Company also provides software and services to enable efficient deployment of NoC IP, hardware security verification software solutions, IP support & maintenance services, professional services and training and on-site support services. The Company is headquartered in Campbell, California and has offices in the United States, France, Poland, Japan, South Korea, Taiwan and China.

COMMON STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) (Details) $ in Thousands	1 Months Ended	3 Months Ended
	Dec. 31, 2025 USD ($) shares	Mar. 31, 2026 USD ($) vote shares	Mar. 31, 2025 shares
Class of Stock [Line Items]
Number of votes per common share \| vote		1,000
Common stock, authorized (in shares) \| shares	300,000,000	300,000,000
Stock repurchased during period (in shares) \| shares		0	0
ATM Offering Program
Class of Stock [Line Items]
Offering of up to	$ 200,000
Gross sales proceeds of up to	$ 75,000
Sale of stock, number of shares issued in transaction (in shares) \| shares		69,636
Sale of stock, consideration received on transaction		$ 1,200
Offering-related costs		700
Net proceeds from sales		$ 500
IPO
Class of Stock [Line Items]
Common stock, authorized (in shares) \| shares		300,000,000

SEGMENT AND GEOGRAPHIC INFORMATION (Details)	3 Months Ended
SEGMENT AND GEOGRAPHIC INFORMATION (Details)	Mar. 31, 2026 segment
Segment Reporting [Abstract]
Number of reportable segments	1

INVESTMENTS - Narrative (Details) - USD ($)	Mar. 31, 2026	Dec. 31, 2025
Investments, Debt and Equity Securities [Abstract]
Continue net unrealized loss position	$ 0	$ 0
Allowance for credit loss	$ 0	$ 0

BUSINESS COMBINATION

3 Months Ended

Mar. 31, 2026

Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]

BUSINESS COMBINATION

Cycuity Acquisition

On January 14, 2026 (the Closing Date), the Company completed the acquisition of Cycuity for approximately $43.1 million, consisting of cash of $15.1 million, the Company’s common stock with a fair value of $19.0 million and earn-out consideration with a fair value of $9.0 million.

Prior to the acquisition, Cycuity was a privately held provider and domain expert of semiconductor cybersecurity assurance technology. By combining innovative system IP from Arteris with leading silicon hardware security assurance technology from Cycuity, the acquisition positions Arteris to address the growing concern around hardware security. The Acquisition has been accounted for in accordance with the acquisition method of accounting for business combinations with the Company as the accounting acquirer.

The preliminary purchase price consideration allocated to the assets acquired and liabilities assumed for the Acquisition is as follows (in thousands):


	JANUARY 14, 2026
Cash consideration paid at closing	$	14,121
Stock consideration	19,016
Cash payments to settle vested awards	971
Contingent consideration	9,018
Total purchase consideration	$	43,126

In connection with the Acquisition, the Company issued 1,096,280 shares of the Company’s common stock. Additionally, the former holders of Cycuity equity securities obtained the right to receive additional contingent consideration of up to $12.0 million. The contingent consideration is based on the achievement of specified bookings targets during the earn-out period from the Closing Date through December 31, 2026, and, if earned, will be payable no later than March 31, 2027. Earn-out payments will be settled in cash for in-the-money option holders and unaccredited investors and in shares of the Company’s common stock for accredited equity holders and warrant holders. The contingent consideration has been accounted for as part of the business combination and was recognized at its acquisition-date fair value as a component of total purchase consideration. The contingent consideration will be remeasured at fair value at each reporting date, with changes in fair value recognized in earnings until the contingency is resolved, and is included in accrued expenses and other current liabilities on the condensed consolidated balance sheets.

Certain outstanding option awards granted by Cycuity were accelerated as a result of the acquisition and paid in cash. As a result, the fair-value of these accelerated option awards of $0.2 million was recognized as a post-combination expense, included in stock-based compensation expense for the three months ended March 31, 2026.

The Company incurred acquisition related expenses associated with the Acquisition of $0.6 million for the three months ended March 31, 2026, which were expensed as incurred in the unaudited condensed consolidated statements of operations.

The purchase price is allocated to identifiable assets acquired and liabilities assumed based on their fair values on the acquisition date, as follows (in thousands):


	Amount
Cash	$	3,914
Accounts receivable	1,415
Prepaid expenses and other current assets	206
Property and equipment, net	34
Intangibles	18,070
Total assets acquired	23,639
Accounts payable	1,007
Deferred revenue, current	2,910
Accrued expenses and other current liabilities	2,959
Deferred tax liability	4,103
Deferred revenue, noncurrent	551
Total liabilities assumed	11,530
Total identifiable net assets	12,109
Goodwill	31,017
Total purchase consideration	$	43,126

Additional information, which existed as of the acquisition date, may become known to the Company during the remainder of the measurement period, a period not to exceed 12 months from the date of the relevant acquisition. Changes to amounts recorded as assets and liabilities may result in a corresponding adjustment to goodwill during the respective measurement period.

The following table summarizes the fair value of the identifiable intangible assets acquired (in thousands) and useful lives:


	Amount		Useful Lives
Developed technology	$	9,600	7 years
Customer relationships	8,300		8 years
Trade name	170		1 year
Total acquired intangibles with definite lives	$	18,070

The fair value of the acquired developed technology intangible assets was determined primarily using the excess earnings method. The fair value of the acquired customer relationships intangible assets was determined using the with-and-without method. The fair value of the acquired trade name intangible assets was determined using the relief-from-royalty method.

Goodwill generated from this business combination is attributed to synergies between the Company and Cycuity’s respective products and services. The Company does not have any tax basis in the total goodwill of $31.0 million and the goodwill is non-deductible for income tax purposes. The Company recorded a one-time non-cash income tax benefit of $4.1 million in the condensed consolidated statement of operations for the three months ended March 31, 2026, related to the release of a portion of the valuation allowance as a result of the acquired intangibles. The revenue and earnings of the acquired business have been included in the Company’s results since the acquisition date.

Pro forma results of operations for the acquisition have not been presented because they are not material to the Company's consolidated results of operations.

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Mar. 31, 2026 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Terminated	false
Nicholas B. Hawkins [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On March 3, 2026, Nicholas B. Hawkins, Chief Financial Officer, cancelled a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 97,092 shares of the Company’s common stock until August 31, 2026.
Name	Nicholas B. Hawkins
Title	Chief Financial Officer
Rule 10b5-1 Arrangement Terminated	true
Termination Date	March 3, 2026
Expiration Date	August 31, 2026
Arrangement Duration	181 days
Aggregate Available	97,092
Paul Alpern February 19 2026 Plan [Member] \| Paul Alpern [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On February 19, 2026, Paul Alpern, Vice President and General Counsel, terminated a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 114,151 shares of the Company’s common stock until August 31, 2026.
Name	Paul Alpern
Title	Vice President and General Counsel
Rule 10b5-1 Arrangement Terminated	true
Termination Date	February 19, 2026
Expiration Date	August 31, 2026
Aggregate Available	114,151
Paul Alpern February 23 2026 Plan [Member] \| Paul Alpern [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On February 23, 2026, Paul Alpern, Vice President and General Counsel, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 106,084 shares of the Company’s common stock until May 31, 2027.
Name	Paul Alpern
Title	Vice President and General Counsel
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	February 23, 2026
Expiration Date	May 31, 2027
Arrangement Duration	462 days
Aggregate Available	106,084

REVENUE - Capitalized Direct Commission Costs (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Revenue from Contract with Customer [Abstract]
Short-term commission capitalized in prepaid expenses and other current assets	$ 3,196	$ 3,124
Long-term commission capitalized in other assets	2,319	2,417
Total	$ 5,515	$ 5,541

REVENUE - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Disaggregation of Revenue [Line Items]
Total revenue	$ 22,936	$ 16,532
Licensing, support and maintenance
Disaggregation of Revenue [Line Items]
Total revenue	19,272	15,335
Variable royalties
Disaggregation of Revenue [Line Items]
Total revenue	2,503	1,167
Professional services and other
Disaggregation of Revenue [Line Items]
Total revenue	$ 1,161	$ 30

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) $ in Thousands		3 Months Ended
	Jan. 14, 2026 USD ($)	Mar. 31, 2026 USD ($) institution obligation segment	Dec. 31, 2025 USD ($)
Property, Plant and Equipment [Line Items]
Number of operating segment \| segment		1
Letters of credit outstanding, amount		$ 300	$ 300
Number of financial institutions \| institution		5
Number of performance obligation \| obligation		2
Cycuity, Inc.
Property, Plant and Equipment [Line Items]
Total purchase consideration	$ 43,126
Cash consideration	15,100
Stock consideration	19,016
Contingent consideration	$ 9,018
Shares committed under the 2021 ESPP
Property, Plant and Equipment [Line Items]
Purchase period		6 months
Discount from fair market value		15.00%
Minimum
Property, Plant and Equipment [Line Items]
Licensing arrangement, period		2 years
Software license, period		1 year
Maximum
Property, Plant and Equipment [Line Items]
Licensing arrangement, period		3 years
Software license, period		3 years

REVENUE - Contract Balances on Condensed Consolidated Balance Sheet (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Revenue from Contract with Customer [Abstract]
Accounts receivable, net	$ 14,694	$ 19,183
Contract assets, current	930	0
Deferred revenue	$ 94,331	$ 95,341

INVESTMENTS - Debt Securities, Available-for-sale (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	$ 38,585	$ 56,259
Unrealized losses and gains	(12)	46
Aggregate Fair Value	38,573	56,305
Corporate bonds
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	19,254	18,304
Unrealized losses and gains	(3)	41
Aggregate Fair Value	19,251	18,345
U.S. treasury securities
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	8,738	3,825
Unrealized losses and gains	(6)	5
Aggregate Fair Value	8,732	3,830
Money market funds
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	5,870	30,661
Unrealized losses and gains	0	0
Aggregate Fair Value	5,870	30,661
U.S. government agency securities
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	4,723	3,469
Unrealized losses and gains	(3)	0
Aggregate Fair Value	$ 4,720	$ 3,469

COMMITMENTS AND CONTINGENCIES (Details)	Oct. 14, 2025 customer
Customer Of Company
Loss Contingencies [Line Items]
Loss contingency, new claims filed, number	3

STOCK-BASED COMPENSATION PLANS AND STOCK-BASED COMPENSATION - Schedule of Stock-Based Compensation Related to Stock-Based Awards to Employees (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	$ 5,511	$ 4,313
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	321	205
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	2,256	1,973
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	1,383	969
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation	$ 1,551	$ 1,166

SEGMENT AND GEOGRAPHIC INFORMATION	3 Months Ended
SEGMENT AND GEOGRAPHIC INFORMATION	Mar. 31, 2026
Segment Reporting [Abstract]
SEGMENT AND GEOGRAPHIC INFORMATION	SEGMENT AND GEOGRAPHIC INFORMATION The Company operates in one reportable segment, as more fully described in Note 2. The Company’s CODM reviews and allocates resources using the Company’s financial performance, primarily the net loss presented in the consolidated statements of operations. Other financial performance measures include Annual Contract Value (ACV), ACV plus royalties and remaining performance obligations. The CODM is regularly provided with only the consolidated expenses as noted on the face of the consolidated statements of operations, that are considered as significant expenses. Interest expense and other income (expense), net as presented in the consolidated statements of operations are not considered as significant expenses.

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Revenue Concentration Risk (Details)	3 Months Ended
	Mar. 31, 2025
Customer A \| Revenue from Contract with Customer Benchmark \| Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	12.00%

STOCK-BASED COMPENSATION PLANS AND STOCK-BASED COMPENSATION - Narrative (Details)	3 Months Ended
	Mar. 31, 2026 USD ($) anniversary shares	Mar. 31, 2025 USD ($) shares	Feb. 28, 2026 shares	Nov. 03, 2022 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercises in period, intrinsic value	$ 900,000	$ 1,300,000
Aggregate intrinsic value, vested	200,000	$ 100,000
Option, cost not yet recognized	$ 1,600,000
Nonvested award, unrecognized, period for recognition	2 years 4 months 24 days
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Nonvested award, unrecognized, period for recognition	2 years 10 months 24 days
Granted (in shares) \| shares	952,513	440,166
Grants in period, vested, grant date fair value	$ 3,900,000	$ 3,700,000
Nonvested award, excluding options, unrecognized	$ 39,600,000
Performance Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Nonvested award, unrecognized, period for recognition	2 years 10 months 24 days
Granted (in shares) \| shares	68,848
Nonvested award, excluding options, unrecognized	$ 1,300,000
Risk-free interest rate	0.00%
Expected dividend yield	$ 0
Total Stockholder Return
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance period	3 years
Anniversary of the award’s grant date \| anniversary	3
Payout will be capped	100.00%
Total Stockholder Return \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Payout percentage	0.00%
Total Stockholder Return \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Payout percentage	200.00%
2022 Employment Inducement Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Capital shares reserved for future issuance (in shares) \| shares			3,603,403	2,000,000

FAIR VALUE MEASUREMENTS - Fair Value, Assets Measured on Recurring Basis (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total cash equivalents	$ 8,365	$ 30,661
Total short-term investments	26,429	20,698
Total long-term investments	3,779	4,946
Total financial assets	38,573	56,305
Level 1
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total cash equivalents	5,870	30,661
Total short-term investments	0	0
Total long-term investments	0	0
Total financial assets	5,870	30,661
Level 2
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total cash equivalents	2,495	0
Total short-term investments	26,429	20,698
Total long-term investments	3,779	4,946
Total financial assets	32,703	25,644
Level 3
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total cash equivalents	0	0
Total short-term investments	0	0
Total long-term investments	0	0
Total financial assets	0	0
Corporate bonds
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total short-term investments	16,597	14,524
Total long-term investments	2,654	3,821
Corporate bonds \| Level 1
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total short-term investments	0	0
Total long-term investments	0	0
Corporate bonds \| Level 2
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total short-term investments	16,597	14,524
Total long-term investments	2,654	3,821
Corporate bonds \| Level 3
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total short-term investments	0	0
Total long-term investments	0	0
U.S. government agency securities
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total short-term investments	3,222	2,969
Total long-term investments	499	500
U.S. government agency securities \| Level 1
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total short-term investments	0	0
Total long-term investments	0	0
U.S. government agency securities \| Level 2
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total short-term investments	3,222	2,969
Total long-term investments	499	500
U.S. government agency securities \| Level 3
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total short-term investments	0	0
Total long-term investments	0	0
U.S. treasury securities
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total short-term investments	6,610	3,205
Total long-term investments	626	625
U.S. treasury securities \| Level 1
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total short-term investments	0	0
Total long-term investments	0	0
U.S. treasury securities \| Level 2
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total short-term investments	6,610	3,205
Total long-term investments	626	625
U.S. treasury securities \| Level 3
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total short-term investments	0	0
Total long-term investments	0	0
Money market funds
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total cash equivalents	5,870	30,661
Money market funds \| Level 1
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total cash equivalents	5,870	30,661
Money market funds \| Level 2
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total cash equivalents	0	0
Money market funds \| Level 3
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total cash equivalents	0	$ 0
U.S. government agency securities
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total cash equivalents	999
U.S. government agency securities \| Level 1
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total cash equivalents	0
U.S. government agency securities \| Level 2
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total cash equivalents	999
U.S. government agency securities \| Level 3
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total cash equivalents	0
U.S. treasury securities
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total cash equivalents	1,496
U.S. treasury securities \| Level 1
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total cash equivalents	0
U.S. treasury securities \| Level 2
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total cash equivalents	1,496
U.S. treasury securities \| Level 3
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Total cash equivalents	$ 0

NET LOSS PER SHARE - Schedule of Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Numerator:
Net loss	$ (7,959)	$ (8,121)
Denominator:
Weighted-average shares outstanding - basic (in shares)	45,544,682	40,853,048
Weighted-average shares outstanding - diluted (in shares)	45,544,682	40,853,048
Net loss per share, basic (in dollars per share)	$ (0.17)	$ (0.20)
Net loss per share, diluted (in dollars per share)	$ (0.17)	$ (0.20)

LEASES - Maturities of Operating Lease Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Feb. 28, 2026	Dec. 31, 2025
Leases [Abstract]
Remainder of 2026	$ 1,337
2027	1,720
2028	1,291
2029	598
2030	419
Thereafter	1,283
Total undiscounted cash flows	6,648
Less: imputed interest	(1,189)
Present value of lease liabilities	5,459	$ 2,700
Operating lease liabilities, current	1,373		$ 1,233
Operating lease liabilities, noncurrent	$ 4,086		$ 3,116

BUSINESS COMBINATION - Schedule of Weighted-average Useful Life (Details) - Cycuity, Inc. $ in Thousands	Jan. 14, 2026 USD ($)
Business Combination [Line Items]
Finite-lived intangible assets acquired	$ 18,070
Developed technology
Business Combination [Line Items]
Finite-lived intangible assets acquired	$ 9,600
Useful Lives	7 years
Customer relationships
Business Combination [Line Items]
Finite-lived intangible assets acquired	$ 8,300
Useful Lives	8 years
Trade name
Business Combination [Line Items]
Finite-lived intangible assets acquired	$ 170
Useful Lives	1 year

BUSINESS COMBINATION - Schedule of Consideration Transferred for Acquisition (Details) - Cycuity, Inc. $ in Thousands	Jan. 14, 2026 USD ($)
Business Combination [Line Items]
Cash consideration paid at closing	$ 14,121
Stock consideration	19,016
Cash payments to settle vested awards	971
Contingent consideration	9,018
Total purchase consideration	$ 43,126

Cover - shares	3 Months Ended
Cover - shares	Mar. 31, 2026	May 05, 2026
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2026
Document Transition Report	false
Entity File Number	001-40960
Entity Registrant Name	Arteris, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-0117058
Entity Address, Address Line One	900 E. Hamilton Ave.
Entity Address, Address Line Two	Suite 300
Entity Address, City or Town	Campbell
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95008
City Area Code	408
Local Phone Number	470-7300
Title of 12(b) Security	Common stock, $0.001 par value
Trading Symbol	AIP
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		46,171,982
Entity Central Index Key	0001667011
Document Fiscal Year Focus	2026
Document Fiscal Period Focus	Q1
Amendment Flag	false
Current Fiscal Year End Date	--12-31

FAIR VALUE MEASUREMENTS - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2026	Dec. 31, 2025
Reported Value Measurement
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Carrying value of term loan and vendor financing agreements	$ 1.3	$ 1.6

COMMON STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)	3 Months Ended
COMMON STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)	Mar. 31, 2026
Equity [Abstract]
COMMON STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)	COMMON STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) Common Stock Holders of common stock are entitled to one vote per share and to receive dividends and, upon liquidation or dissolution, are entitled to receive all assets available for distribution to common stockholders. The common stock has no preemptive or other subscription rights and there are no redemption or sinking fund provisions with respect to such shares. Common stock is subordinate to the preferred stock with respect to dividend rights and rights upon liquidation, winding-up, and dissolution of the Company. In connection with its Initial Public Offering in October 2021, the Company amended and restated its certificate of incorporation to authorize 300,000,000 shares of common stock. Stock Repurchases There were no repurchased shares for both the three months ended March 31, 2026 and 2025. Sales of Common Stock Under At-the-Market Offering In December 2025, the Company filed a Registration Statement on Form S-3 covering the offering of up to $200.0 million of common stock, preferred stock, debt securities, warrants and units, which was declared effective by the SEC on December 23, 2025 (the S-3 Registration Statement). On December 11, 2025, the Company also entered into an Open Market Sales Agreement (the Sales Agreement) with Jefferies LLC as sales agent to sell shares of the Company’s common stock, from time to time, with aggregate gross sales proceeds of up to $75.0 million pursuant to the S-3 Registration Statement as an “at-the-market” offering under the Securities Act (the 2025 ATM Offering Program). During the three months ended March 31, 2026, the Company utilized the 2025 ATM Offering Program and sold 69,636 shares of common stock for gross proceeds of $1.2 million, before deducting commissions and offering-related costs of $0.7 million. Net proceeds of $0.5 million from these sales were recorded in additional paid-in capital within stockholders’ equity.

BUSINESS COMBINATION - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended
	Jan. 14, 2026	Mar. 31, 2026	Dec. 31, 2025
Business Combination [Line Items]
Goodwill		$ 35,195	$ 4,178
Cycuity, Inc.
Business Combination [Line Items]
Total purchase consideration	$ 43,126
Payments to acquire business, gross	15,100
Stock consideration	19,016
Contingent consideration	$ 9,018
Stock consideration (in shares)	1,096,280
Additional contingent consideration of up	$ 12,000
Post-combination expense		200
Integration related expenses		600
Goodwill	$ 31,017	31,000
Change in deferred tax assets valuation allowance, amount		$ 4,100

RELATED PARTY TRANSACTIONS	3 Months Ended
RELATED PARTY TRANSACTIONS	Mar. 31, 2026
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS The Company defines related parties as directors, executive officers, nominees for director and stockholders that have significant influence over the Company, or are a greater than 10% beneficial owner of the Company’s capital and their affiliates or immediate family members. Transchip, an equity method investee of the Company, is also deemed as a related party. On November 15, 2024, the Company entered into a design services licensing collaboration agreement with Transchip. This arrangement gives Transchip a non-exclusive license right to make design house offerings using certain of the Company's products. The Company retains the manufacturing and royalty-related rights in relation to the Company’s products used in the design house offerings. During the three months ended March 31, 2025, the Company delivered a three-year term license to Transchip under this arrangement. The Company received payment recorded as accounts receivable of $0.7 million and recognized revenue of $0.1 million during the three months ended March 31, 2026. K. Charles Janac, the Company’s Chief Executive Officer, invested $0.3 million of his own funds in a private equity financing of an AI chatbot startup, Biflow AI Inc., (Biflow). Following his investment, Mr. Janac controls less than 5% of the outstanding equity of Biflow, on an as converted basis. In addition, Mr. Janac is also an advisor to Biflow. Biflow was co-founded by a son of one of the Company’s employees, an executive vice president. In September 2025, the Company entered into a separately negotiated agreement with Biflow to provide chatbot services and paid $10,000 to Biflow under the agreement during the three months ended March 31, 2026. In April 2026, the Company entered into an amendment to the September 2025 agreement with Biflow to provide additional services to the Company for an amount of $0.1 million through March 2027.

REVENUE - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
REVENUE - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025
Disaggregation of Revenue [Line Items]
Deferred revenue, revenue recognized	$ 18.6	$ 13.5
Unsatisfied performance obligations	114.9
Revenue, remaining performance obligation, flexible spending account commitment	3.5		$ 3.8
Amortization of capitalized sales commissions	1.1	$ 0.8
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-04-01
Disaggregation of Revenue [Line Items]
Unsatisfied performance obligations, excluding flexible spending account commitment	$ 62.4
Remaining performance obligation, expected timing of satisfaction	12 months

NET LOSS PER SHARE - Schedule of Potentially Dilutive Securities Excluded from the Calculation of Diluted Earnings Per Share (Details) - shares	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	6,501,686	7,737,471
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	1,627,772	2,331,645
Restricted stock units and other
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	4,817,255	5,087,569
Restricted common shares issued for business combination
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	0	234,859
Shares committed under the 2021 ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	56,659	83,398

STOCK-BASED COMPENSATION PLANS AND STOCK-BASED COMPENSATION - Schedule of Restricted and Performance Stock Units and Awards Activity (Details) - Restricted and Performance Stock Units	3 Months Ended
	Mar. 31, 2026 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Unvested, Balance at beginning of period (in shares) \| shares	4,355,001
Granted (in shares) \| shares	1,021,361
Vested (in shares) \| shares	(507,802)
Forfeited (in shares) \| shares	(51,305)
Unvested, Balance at end of period (in shares) \| shares	4,817,255
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Unvested, Balance at beginning of period (in dollars per share) \| $ / shares	$ 7.68
Granted (in dollars per share) \| $ / shares	16.70
Vested (in dollars per share) \| $ / shares	7.73
Forfeited (in dollars per share) \| $ / shares	9.24
Unvested, Balance at end of period (in dollars per share) \| $ / shares	$ 9.57

EQUITY METHOD INVESTMENT (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended
EQUITY METHOD INVESTMENT (Details) - USD ($) $ in Thousands	Sep. 30, 2025	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025
Subsidiary or Equity Method Investee [Line Items]
Equity method investment		$ 0		$ 2,989
TransChip Technology
Subsidiary or Equity Method Investee [Line Items]
Ownership percentage on issued and outstanding shares		36.90%		42.70%
Ownership percentage		35.00%
Stock-based compensation expense		$ 2,300
TransChip Technology
Subsidiary or Equity Method Investee [Line Items]
Received from convertible bond investment agreement as a loan	$ 5,600
Equity method investment, transaction costs		$ 3,000	$ 800

INTANGIBLE ASSETS AND GOODWILL - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 23,690	$ 5,620
Finite-lived intangible assets, accumulated amortization	(4,142)	(3,452)
Total future amortization expense	19,398
Intangible assets, net	19,548	2,168
Trade name and other
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	370
Indefinite-lived intangible assets, gross		200
Finite-lived intangible assets, accumulated amortization	(74)	(33)
Total future amortization expense	296	167
Developed technology
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	13,190	3,590
Finite-lived intangible assets, accumulated amortization	(2,815)	(2,446)
Total future amortization expense	10,375	1,144
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible assets, gross	10,130	1,830
Finite-lived intangible assets, accumulated amortization	(1,253)	(973)
Total future amortization expense	$ 8,877	$ 857

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 11,674	$ 33,901
Short-term investments (Note 5)	26,429	20,698
Accounts receivable, net of allowance of $73 as of both March 31, 2026 and December 31, 2025	14,694	19,183
Prepaid expenses and other current assets	8,740	8,608
Total current assets	61,537	82,390
Property and equipment, net	3,594	3,872
Long-term investments (Note 5)	3,779	4,946
Equity method investment	0	2,989
Operating lease right-of-use assets	5,165	3,919
Intangibles, net	19,548	2,168
Goodwill	35,195	4,178
Other assets	11,058	10,569
TOTAL ASSETS	139,876	115,031
Current liabilities:
Accounts payable	563	340
Accrued expenses and other current liabilities	27,028	19,094
Operating lease liabilities, current	1,373	1,233
Deferred revenue, current	54,729	51,367
Vendor financing arrangements, current	829	1,166
Total current liabilities	84,522	73,200
Deferred revenue, noncurrent	39,602	43,974
Operating lease liabilities, noncurrent	4,086	3,116
Vendor financing arrangements, noncurrent	452	452
Deferred income, noncurrent	6,161	6,452
Other liabilities	2,462	2,469
Total liabilities	137,285	129,663
Commitments and contingencies (Note 11)
Stockholders' equity (deficit):
Preferred stock, par value of $0.001 - 10,000,000 shares authorized and no shares issued and outstanding as of both March 31, 2026 and December 31, 2025	0	0
Common stock, par value of $0.001 - 300,000,000 shares authorized as of both March 31, 2026 and December 31, 2025; 46,017,908 and 44,268,816 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	46	44
Additional paid-in capital	182,014	156,776
Accumulated other comprehensive income	121	179
Accumulated deficit	(179,590)	(171,631)
Total stockholders' equity (deficit)	2,591	(14,632)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	$ 139,876	$ 115,031

LEASES - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
LEASES - Narrative (Details) - USD ($) $ in Thousands	Mar. 31, 2026	Mar. 31, 2025	Feb. 28, 2026	Dec. 31, 2025
Leases [Abstract]
Weighted average remaining lease term, operating lease	5 years 1 month 6 days			3 years 9 months 18 days
Weighted average discount rate, operating lease	7.00%			10.00%
Cash payments	$ 300	$ 300
Future lease payment	$ 5,459		$ 2,700
Lease term			9 years

RELATED PARTY TRANSACTIONS (Details) - USD ($)	1 Months Ended	3 Months Ended
RELATED PARTY TRANSACTIONS (Details) - USD ($)	Apr. 30, 2026	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025
Related Party Transaction [Line Items]
Accounts receivable and deferred revenue		$ 14,694,000		$ 19,183,000
Revenue		22,936,000	$ 16,532,000
Total stock-based compensation		5,511,000	$ 4,313,000
TransChip Technology \| Collaboration Agreement
Related Party Transaction [Line Items]
Consulting agreement, term			3 years
Accounts receivable and deferred revenue		700,000
Revenue		100,000
K. Charles Janac \| Consulting Agreement \| Director
Related Party Transaction [Line Items]
Total stock-based compensation		$ 300,000
Outstanding equity		5.00%
Professional fees		$ 10,000
K. Charles Janac \| Consulting Agreement \| Director \| Subsequent Event
Related Party Transaction [Line Items]
Professional fees	$ 100,000

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Revenue
Total revenue	$ 22,936	$ 16,532
Cost of revenue	3,250	1,526
Gross profit	19,686	15,006
Operating expenses:
Research and development	14,457	11,862
Sales and marketing	8,530	6,529
General and administrative	5,415	4,323
Acquisition related costs	584	0
Total operating expenses	28,986	22,714
Loss from operations	(9,300)	(7,708)
Interest expense	(38)	(48)
Other income (expense), net	670	718
Loss before income taxes and loss from equity method investment	(8,668)	(7,038)
Loss from equity method investment, net of tax	2,989	815
Loss before income taxes	(11,657)	(7,853)
Provision for (benefit from) income taxes	(3,698)	268
Net loss	$ (7,959)	$ (8,121)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.17)	$ (0.20)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.17)	$ (0.20)
Weighted-average shares used in computing per share amounts, basic (in shares)	45,544,682	40,853,048
Weighted-average shares used in computing per share amounts, basic (in shares)	45,544,682	40,853,048
Licensing, support and maintenance
Revenue
Total revenue	$ 19,272	$ 15,335
Variable royalties
Revenue
Total revenue	2,503	1,167
Professional services and other
Revenue
Total revenue	$ 1,161	$ 30